Sep 15, 2021 / 04:30PM GMT
Jim Forbes -
Good afternoon, and welcome to the Morgan Stanley Global Healthcare Conference. Pleased to have with us today the senior management team of MEDNAX. We've got Mark Ordan, the President and CEO; Jim Swift, the Executive Vice President, responsible for Corporate Development; and Charlie Lynch, EVP of Finance and Strategy.
We do have a disclaimer I have to read, and I will do that first. And I would also remind the audience that we have a Q&A portal. You can submit questions into the Q&A porta at any time. And so please do that.
The disclaimer, for important disclosures, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Mark, Jim, Charlie, thank you very much for participating in our conference. We've already got some questions. So I'm going to start off here.
MEDNAX Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot